Mitochondrial protection by the mixed muscarinic/σ1 ligand anavex2-73, a tetrahydrofuran derivative, in aβ25-35 peptide-injected mice, a nontransgenic alzheimer’s disease model

HIGHLIGHTS

• who: Tangui Maurice from the 10, University of Montpellier, Montpellier, France have published the research work: Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25-35 peptide-injected mice, a nontransgenic Alzheimer's disease model, in the Journal: (JOURNAL)
• what: The authors showed that mitochondrial functionality was altered several days after an ICV injection of the Aβ25-35 peptide Frontiers in Cellular Neuroscience in mouse. The aim of the study was to establish whether the localization of the σ1 R on mitochondria (Klouz et_al, 2002) and more . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.